Literature DB >> 16047138

Drug-drug interactions among recently hospitalised patients--frequent but mostly clinically insignificant.

Bente Glintborg1, Stig Ejdrup Andersen, Kim Dalhoff.   

Abstract

OBJECTIVE: Patients use and store considerable amounts of drugs. The aim of the present study was to identify potential drug-drug interactions between drugs used by patients recently discharged from the hospital and, subsequently, to estimate the clinical implications of these interactions.
METHODS: Patients were visited within 1 week following their discharge from hospital and interviewed about their drug use. Stored products were inspected. We used a bibliography (Hansten and Horn; Wolters Kluwer Health, St. Louis, Mo., 2004) to identify and classify potential drug-drug interactions.
RESULTS: In total, 83 surgical and 117 medical patients (n = 200) were included in the survey, of which 139 (70%) were women. The median age was 75 years (range: 24-100 years). Patients stored 2119 medications at home (median: nine per patient; range: 2-44) and used 1622 medications daily or on demand (median: eight per patient; range: 1-24). With respect to those drugs used daily or on demand, 476 potential interactions were identified (126 patients); none were class 1 (always avoid drug combination) and 25 were class 2 (usually avoid combination; 24 patients). Eleven of the potential class 2 interactions involved over-the-counter products (aspirin and ginkgo biloba). Of the 52 drugs involved in potential class 2 interactions, 50 had been used for more than 1 month. According to the hospital case notes, none of the potential class 2 interactions had actually caused adverse effects.
CONCLUSION: Although potential drug-drug interactions are highly prevalent, serious and clinically significant interactions are rare among recently hospitalised patients.

Entities:  

Mesh:

Year:  2005        PMID: 16047138     DOI: 10.1007/s00228-005-0978-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  28 in total

1.  Medication control in hospitals: a practical approach to the problem of drug-drug interactions.

Authors:  E H Wiltink
Journal:  Pharm World Sci       Date:  1998-08

Review 2.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Drug compliance and unreported drugs in the elderly.

Authors:  A Spagnoli; G Ostino; A D Borga; R D'Ambrosio; P Maggiorotti; E Todisco; W Prattichizzo; L Pia; M Comelli
Journal:  J Am Geriatr Soc       Date:  1989-07       Impact factor: 5.562

4.  The consumption of drugs by 75-year-old individuals living in their own homes.

Authors:  I Barat; F Andreasen; E M Damsgaard
Journal:  Eur J Clin Pharmacol       Date:  2000-09       Impact factor: 2.953

5.  Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients.

Authors:  J Doucet; P Chassagne; C Trivalle; I Landrin; M D Pauty; N Kadri; J F Ménard; E Bercoff
Journal:  J Am Geriatr Soc       Date:  1996-08       Impact factor: 5.562

6.  Over-the-counter medication: the drug interactions we overlook.

Authors:  P P Lamy
Journal:  J Am Geriatr Soc       Date:  1982-11       Impact factor: 5.562

7.  Potential adverse drug interactions in the emergency room. An issue in the quality of care.

Authors:  M H Beers; M Storrie; G Lee
Journal:  Ann Intern Med       Date:  1990-01-01       Impact factor: 25.391

Review 8.  Drug-related hospital admissions.

Authors:  T R Einarson
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154

9.  Potential drug interactions in surgical patients.

Authors:  C W Durrence; J T DiPiro; J R May; R R Nesbit; J F Sisley; J W Cooper
Journal:  Am J Hosp Pharm       Date:  1985-07

10.  Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices.

Authors:  Catherine C Peng; Peter A Glassman; Lauren E Trilli; Jocelyn Hayes-Hunter; Chester B Good
Journal:  Arch Intern Med       Date:  2004-03-22
View more
  34 in total

1.  The incidence of potential drug-drug interactions in elderly patients with arterial hypertension.

Authors:  Vesna Bacic-Vrca; Srecko Marusic; Viktorija Erdeljic; Slaven Falamic; Nives Gojo-Tomic; Dario Rahelic
Journal:  Pharm World Sci       Date:  2010-10-05

2.  Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.

Authors:  Roberto Leone; Lara Magro; Ugo Moretti; Paola Cutroneo; Martina Moschini; Domenico Motola; Marco Tuccori; Anita Conforti
Journal:  Drug Saf       Date:  2010-08-01       Impact factor: 5.606

3.  Potential drug-drug interactions on in-patient medication prescriptions at Mbarara Regional Referral Hospital (MRRH) in western Uganda: prevalence, clinical importance and associated factors.

Authors:  S J Lubinga; E Uwiduhaye
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

4.  Use of an online surveillance system for screening drug interactions in prescriptions in community pharmacies.

Authors:  Tiina Heikkilä; Tuula Lekander; Hannu Raunio
Journal:  Eur J Clin Pharmacol       Date:  2006-06-22       Impact factor: 2.953

5.  Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61: 675-681).

Authors:  Mark Naunton; Michiel Duyvendak; Gregory M Peterson; Jacobus R J B Brouwers
Journal:  Eur J Clin Pharmacol       Date:  2006-01-12       Impact factor: 2.953

6.  Evaluation of drug-drug interaction screening software combined with pharmacist intervention.

Authors:  Cristiano S Moura; Nília M Prado; Najara O Belo; Francisco A Acurcio
Journal:  Int J Clin Pharm       Date:  2012-04-26

7.  Pharmacy students' retention of knowledge of drug-drug interactions.

Authors:  Adrienne M Gilligan; Terri L Warholak; John E Murphy; Lisa E Hines; Daniel C Malone
Journal:  Am J Pharm Educ       Date:  2011-08-10       Impact factor: 2.047

8.  Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort study.

Authors:  Neža Muhič; Ales Mrhar; Miran Brvar
Journal:  Eur J Clin Pharmacol       Date:  2017-03-15       Impact factor: 2.953

9.  Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system.

Authors:  Sigrid Narum; Vigdis Solhaug; Kirsten Myhr; Odd Brørs; Marianne Kristiansen Kringen
Journal:  Eur J Clin Pharmacol       Date:  2013-02-20       Impact factor: 2.953

10.  Identification of severe potential drug-drug interactions using an Italian general-practitioner database.

Authors:  L Magro; A Conforti; F Del Zotti; R Leone; M L Iorio; I Meneghelli; D Massignani; E Visonà; U Moretti
Journal:  Eur J Clin Pharmacol       Date:  2007-11-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.